[Skip to Content]
[Skip to Content Landing]
Editorial
July 2018

When Low-Risk Atrial Fibrillation Is Not So Low Risk: Beast of Burden

Author Affiliations
  • 1Division of Cardiovascular Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah
  • 2Duke Center for Atrial Fibrillation, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
JAMA Cardiol. 2018;3(7):558-560. doi:10.1001/jamacardio.2018.1205

The association between atrial fibrillation (AF) and stroke has been well described, dating back to early observational data from the Framingham Heart Study.1 In that cohort, there was a 5-fold increased risk of stroke among patients with AF. These data, in part, led to the development of robust clinical evidence that supported the net clinical benefit of oral anticoagulation (OAC) therapy to reduce the risk of stroke in patients with AF.2

×